已經(jīng)發(fā)現(xiàn)CD 90在許多細(xì)胞活動(dòng)中起作用,例如細(xì)胞粘附、凋亡、轉(zhuǎn)移、炎癥和纖維化。在表達(dá)CD90.1的小鼠品系中,其在骨髓中的早期造血細(xì)胞、胸腺細(xì)胞和循環(huán)成熟T細(xì)胞上表達(dá)。據(jù)報(bào)道,OX-7抗體可誘導(dǎo)白細(xì)胞活化、腎小球腎炎、腎小球系膜細(xì)胞凋亡和血管通透性。CD 90可用作多種干細(xì)胞和成熟神經(jīng)元軸突突起的標(biāo)記物。與CD 90功能障礙相關(guān)的疾病包括鼻咽癌和胸腺瘤。 抗小鼠CD90.1(OX-7)體內(nèi)抗體-低內(nèi)毒素該產(chǎn)品同種型對(duì)照:Mouse IgG1 Isotype Control for In Vivo – Low Endotoxin (HKSP84) [ICH2248] 緩沖液:ICH3001-100ml,nICH3002-100ml,nICH3003-100ml, 濃度:≥ 2.0 mg/ml 純度:>95% by SDS-PAGE 內(nèi)毒素:<1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.